Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fertility After Transvaginal Surgery or Uterine Artery Embolization Combined With Uterine Curettage in Patients With Cesarean Scar Pregnancy

NCT02933190 is registered in ClinicalTrials.gov with Shanghai First Maternity and Infant Hospital as lead sponsor.

NCT NCT02933190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02933190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fertility After Transvaginal Surgery or Uterine Artery Embolization Combined With Uterine Curettage in Patients With Cesarean Scar Pregnancy
Lead sponsor
Shanghai First Maternity and Infant Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2016
Completion date
December 31, 2019
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

magnetic resonance imaging, menstruation, ovarian function